Ensign Peak Advisors’s Olema Pharmaceuticals OLMA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-18,849
| Closed | -$110K | – | 1713 |
|
|
2024
Q4 | $110K | Hold |
18,849
| – | – | ﹤0.01% | 1702 |
|
|
2024
Q3 | $225K | Buy |
18,849
+4,000
| +27% | +$47.8K | ﹤0.01% | 1687 |
|
|
2024
Q2 | $161K | Buy |
14,849
+850
| +6% | +$9.2K | ﹤0.01% | 1701 |
|
|
2024
Q1 | $158K | Buy |
+13,999
| New | +$158K | ﹤0.01% | 1713 |
|
|
2021
Q3 | – | Sell |
-9,800
| Closed | -$275K | – | 1869 |
|
|
2021
Q2 | $275K | Buy |
9,800
+3,200
| +48% | +$89.8K | ﹤0.01% | 1685 |
|
|
2021
Q1 | $219K | Buy |
+6,600
| New | +$219K | ﹤0.01% | 1720 |
|